Literature DB >> 8780382

HMGI-C expression patterns in human tissues. Implications for the genesis of frequent mesenchymal tumors.

P Rogalla1, K Drechsler, G Frey, Y Hennig, B Helmke, U Bonk, J Bullerdiek.   

Abstract

Cytogenetically visible aberrations of chromosomal region 12q14-15 in a variety of frequent benign human tumors reflect rearrangements of the HMGI-C gene. The mechanisms by which the HMGI-C gene contributes to tumorigenesis are mostly unknown, although frequently aberrant transcripts containing exons 1 to 3 of HMGI-C and ectopic sequences from other genes due to breaks within the third intron of HMGI-C are detectable. This is the first report analyzing human tissue samples mainly of mesenchymal origin by a highly sensitive polymerase-chain-reaction-based approach detecting HMGI-C expression. We found HMGI-C expression in embryonic tissue but no expression in any of several adult tissues tested except for two myometrial tissues. These data suggest that HMGI-C is mainly expressed in human tissues during embryonal and fetal development. Thus, its particular role for tumor development may be due to the expression of at least exons 1 to 3 rather than to the formation of fusion transcripts.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8780382      PMCID: PMC1865134     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  16 in total

1.  Telomere repeat fragment sizes do not limit the growth potential of uterine leiomyomas.

Authors:  P Rogalla; C Rohen; Y Hennig; U Deichert; U Bonk; J Bullerdiek
Journal:  Biochem Biophys Res Commun       Date:  1995-06-06       Impact factor: 3.575

2.  Expression of SV40 T-antigen in lipoma cells with a chromosomal translocation T(3;12) is not sufficient for direct immortalization.

Authors:  G Belge; B Kazmierczak; K Meyer-Bolte; S Bartnitzke; J Bullerdiek
Journal:  Cell Biol Int Rep       Date:  1992-04

3.  Disruption of the architectural factor HMGI-C: DNA-binding AT hook motifs fused in lipomas to distinct transcriptional regulatory domains.

Authors:  H R Ashar; M S Fejzo; A Tkachenko; X Zhou; J A Fletcher; S Weremowicz; C C Morton; K Chada
Journal:  Cell       Date:  1995-07-14       Impact factor: 41.582

4.  Mutation responsible for the mouse pygmy phenotype in the developmentally regulated factor HMGI-C.

Authors:  X Zhou; K F Benson; H R Ashar; K Chada
Journal:  Nature       Date:  1995-08-31       Impact factor: 49.962

5.  Molecular characterization of MAR, a multiple aberration region on human chromosome segment 12q13-q15 implicated in various solid tumors.

Authors:  W J Van de Ven; E F Schoenmakers; S Wanschura; B Kazmierczak; P F Kools; J M Geurts; S Bartnitzke; H Van den Berghe; J Bullerdiek
Journal:  Genes Chromosomes Cancer       Date:  1995-04       Impact factor: 5.006

6.  Cytogenic and molecular analysis of an aggressive angiomyxoma.

Authors:  B Kazmierczak; S Wanschura; K Meyer-Bolte; J Caselitz; P Meister; S Bartnitzke; W Van de Ven; J Bullerdiek
Journal:  Am J Pathol       Date:  1995-09       Impact factor: 4.307

7.  Recurrent rearrangements in the high mobility group protein gene, HMGI-C, in benign mesenchymal tumours.

Authors:  E F Schoenmakers; S Wanschura; R Mols; J Bullerdiek; H Van den Berghe; W J Van de Ven
Journal:  Nat Genet       Date:  1995-08       Impact factor: 38.330

8.  A fibroadenoma with a t(4;12) (q27;q15) affecting the HMGI-C gene, a member of the high mobility group protein gene family.

Authors:  B Staats; U Bonk; S Wanschura; P Hanisch; E F Schoenmakers; W J Van de Ven; S Bartnitzke; J Bullerdiek
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

9.  Molecular characterization of 12q14-15 rearrangements in three pulmonary chondroid hamartomas.

Authors:  B Kazmierczak; S Wanschura; J Rosigkeit; K Meyer-Bolte; K Uschinsky; R Haupt; E F Schoenmakers; S Bartnitzke; W J Van de Ven; J Bullerdiek
Journal:  Cancer Res       Date:  1995-06-15       Impact factor: 12.701

10.  Identification, molecular cloning, and characterization of the chromosome 12 breakpoint cluster region of uterine leiomyomas.

Authors:  E F Schoenmakers; R Mols; S Wanschura; P F Kools; J M Geurts; S Bartnitzke; J Bullerdiek; H van den Berghe; W J Van de Ven
Journal:  Genes Chromosomes Cancer       Date:  1994-10       Impact factor: 5.006

View more
  64 in total

1.  Expression of the high-mobility group protein HMGI(Y) in human trophoblast: potential role in trophoblast invasion of maternal tissue.

Authors:  Ana-Maria Bamberger; Antonis Makrigiannakis; Kerstin Röser; Jessica Radde; Tanja Carstens; Aljoscha M Flohr; Christoph M Bamberger; Jörn Bullerdiek; Thomas Löning
Journal:  Virchows Arch       Date:  2003-09-11       Impact factor: 4.064

2.  Expression of high mobility group A2 is associated with poor survival in hepatocellular carcinoma.

Authors:  Lielin Wu; Zhiming Wang; Rongli Lu; Wei Jiang
Journal:  Pathol Oncol Res       Date:  2012-03-30       Impact factor: 3.201

3.  HMGI-C suppressing induces P53/caspase9 axis to regulate apoptosis in breast adenocarcinoma cells.

Authors:  Behzad Mansoori; Ali Mohammadi; Solmaz Shirjang; Behzad Baradaran
Journal:  Cell Cycle       Date:  2016-05-31       Impact factor: 4.534

4.  Gene expressions of HMGI-C and HMGI(Y) are associated with stage and metastasis in colorectal cancer.

Authors:  Meng-Lin Huang; Chou-Chan Chen; Li-Ching Chang
Journal:  Int J Colorectal Dis       Date:  2009-07-17       Impact factor: 2.571

5.  siRNA-Mediated Silencing of HMGA2 Induces Apoptosis and Cell Cycle Arrest in Human Colorectal Carcinoma.

Authors:  Sahar Esmailzadeh; Behzad Mansoori; Ali Mohammadi; Dariush Shanehbandi; Behzad Baradaran
Journal:  J Gastrointest Cancer       Date:  2017-06

6.  Identification of target genes for wild type and truncated HMGA2 in mesenchymal stem-like cells.

Authors:  Jørn Henriksen; Marianne Stabell; Leonardo A Meza-Zepeda; Silje Au Lauvrak; Moustapha Kassem; Ola Myklebost
Journal:  BMC Cancer       Date:  2010-06-25       Impact factor: 4.430

7.  Effect of silencing of high mobility group A2 gene on gastric cancer MKN-45 cells.

Authors:  Chun-Hui Wei; Li-Xiu Wei; Ming-Yu Lai; Jia-Zhuang Chen; Xi-Jing Mo
Journal:  World J Gastroenterol       Date:  2013-02-28       Impact factor: 5.742

8.  A novel truncated form of HMGA2 in tumors of the ovaries.

Authors:  Antonio Agostini; Ioannis Panagopoulos; Ben Davidson; Claes Goran Trope; Sverre Heim; Francesca Micci
Journal:  Oncol Lett       Date:  2016-06-29       Impact factor: 2.967

9.  Expression of high-mobility-group-protein HMGI-C mRNA in the peripheral blood is an independent poor prognostic indicator for survival in metastatic breast cancer.

Authors:  C Langelotz; P Schmid; C Jakob; U Heider; K D Wernecke; K Possinger; O Sezer
Journal:  Br J Cancer       Date:  2003-05-06       Impact factor: 7.640

10.  Expression levels of HMGA2 in adipocytic tumors correlate with morphologic and cytogenetic subgroups.

Authors:  Hammurabi Bartuma; Ioannis Panagopoulos; Anna Collin; Domenico Trombetta; Henryk A Domanski; Nils Mandahl; Fredrik Mertens
Journal:  Mol Cancer       Date:  2009-06-09       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.